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SUPPLEMENTAL TABLE 7  Adjusted ORs and 95% CIs for Relative Effectiveness of LAIV to IIV by Influenza Season and Age Group Where Study Population Is 
Restricted to Those Without High-Risk Health Conditions
Influenza Season Age Group, y Vaccine Total No. (%) Influenza Positive Adjusted ORa (95% CI)
2010–2011 2–17 LAIV 111 20 (18) 1.58 (0.78 to 3.22)
IIV 327 39 (12) Reference
2–8 LAIV 76 14 (18) 1.78 (0.71 to 4.55)
IIV 209 23 (11) Reference
9–17 LAIV 35 6 (17) 1.84 (0.37 to 9.09)
IIV 118 16 (14) Reference
2011–2012 2–17 LAIV 139 11 (8) 0.61 (0.26 to 1.41)
IIV 355 41 (12) Reference
2–8 LAIV 89 6 (7) 0.49 (0.15 to 1.61)
IIV 241 25 (10) Reference
9–17 LAIV 50 5 (10) 0.57 (0.15 to 2.22)
IIV 114 16 (14) Reference
2012–2013 2–17 LAIV 178 56 (31) 0.97 (0.63 to 1.51)
IIV 406 131 (32) Reference
2–8 LAIV 111 32 (29) 0.86 (0.46 to 1.59)
IIV 243 69 (28) Reference
9–17 LAIV 67 24 (36) 1.15 (0.57 to 2.33)
IIV 163 62 (28) Reference
2013–2014 2–17 LAIV 147 31 (21) 2.54 (1.38 to 4.67)
IIV 325 31 (10) Reference
2–8 LAIV 84 20 (24) 3.97 (1.73 to 9.13)
IIV 220 18 (8) Reference
9–17 LAIV 63 11 (17) 1.79 (0.62 to 5.19)
IIV 105 13 (12) Reference
a Fully adjusted models included age (group or years), gender, study site, race or ethnicity, parent- or guardian-rated general health status, interval from onset to enrollment, and calendar 
time (2-wk intervals).
SUPPLEMENTAL TABLE 8  Adjusted ORs and 95% CIs for Relative Effectiveness of LAIV to IIV by Influenza Season and Age Group Where Study Population 
Includes Partially Vaccinated Participants
Influenza Season Age Group, y Vaccine Total No. (%) Influenza Positive Adjusted ORa (95% CI)
2010–2011 2–17 LAIV 159 27 (17) 1.21 (0.71 to 2.07)
IIV 617 92 (15) Reference
2–8 LAIV 121 20 (17) 1.14 (0.60 to 2.17)
IIV 436 61 (14) Reference
2011–2012 2–17 LAIV 177 16 (9) 0.73 (0.38 to 1.39)
IIV 580 65 (11) Reference
2–8 LAIV 121 10 (8) 0.63 (0.28 to 1.43)
IIV 406 45 (11) Reference
2012–2013 2–17 LAIV 233 67 (29) 0.92 (0.64 to 1.33)
IIV 705 223 (32) Reference
2–8 LAIV 156 41 (26) 0.71 (0.44 to 1.13)
IIV 454 135 (30) Reference
2013–2014 2–17 LAIV 178 36 (20) 3.22 (1.85 to 5.61)
IIV 514 37 (7) Reference
2–8 LAIV 106 24 (23) 5.83 (2.69 to 12.62)
IIV 351 22 (6) Reference
a Adjusted models included age at enrollment (groups), gender, study site, race or ethnicity, presence of high-risk health condition, parent- or guardian-rated general health status, interval 
from onset to enrollment, and calendar time (2-wk intervals).
